ArticleCell reports. Medicine2024

Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.

Anouk M D Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.